Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Tavazzi

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Antioxidants (Basel, Switzerland)|February 26, 2025
(Poly)phenols and Multiple Sclerosis: Results from an Observational Cross-Sectional StudyMonica Guglielmetti, Cinzia Ferraris, Anna Tagliabue, et al.
Neuroimage|May 15, 2007
Quantitative diffusion weighted imaging measures in patients with multiple sclerosisEleonora Tavazzi, Michael G Dwyer, Bianca Weinstock-Guttman, et al.
Frontiers in Neurology|December 8, 2022
Barriers to exercise and the role of general practitioner: A cross-sectional survey among people with multiple sclerosisLuca Correale, Luca Martinis, Eleonora Tavazzi, et al.
Journal of the Neurological Sciences|March 25, 2018
Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI studyRobert Zivadinov, Niels Bergsland, Jesper Hagemeier, et al.
Journal of Biomedical Semantics|August 29, 2024
An extensible and unifying approach to retrospective clinical data modeling: the BrainTeaser OntologyGuglielmo Faggioli, Laura Menotti, Stefano Marchesin, et al.
Journal of Neurology|January 10, 2026
Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatmentsGiacomo Greco, Giovanni Della Porta, Francesco Masi, et al.
Journal of Neurology|August 21, 2025
Paramagnetic rim lesions are associated with choroid plexus inflammation and expansion over 5 years in people with multiple sclerosisJack A Reeves, Ashley Tranquille, Alexander Bartnik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 31, 2026
The supporting role of Visual Evoked Potentials for the diagnosis of Optic Neuritis within the 2022 ICON criteriaGiacomo Greco, Eleonora Rigoni, Francesco Masi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Immunomodulatory therapies delay disease progression in multiple sclerosisRoberto Bergamaschi, Silvana Quaglini, Eleonora Tavazzi, et al.
Nutrients|February 13, 2025
Dietary Inflammatory Score (DIS)'s and Lifestyle Inflammatory Score (LIS)'s Impact on Multiple Sclerosis SeverityMonica Guglielmetti, Cinzia Ferraris, Lenycia de Cassya Lopes Neri, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Antioxidants (Basel, Switzerland)|February 26, 2025
(Poly)phenols and Multiple Sclerosis: Results from an Observational Cross-Sectional StudyMonica Guglielmetti, Cinzia Ferraris, Anna Tagliabue, et al.
Neuroimage|May 15, 2007
Quantitative diffusion weighted imaging measures in patients with multiple sclerosisEleonora Tavazzi, Michael G Dwyer, Bianca Weinstock-Guttman, et al.
Frontiers in Neurology|December 8, 2022
Barriers to exercise and the role of general practitioner: A cross-sectional survey among people with multiple sclerosisLuca Correale, Luca Martinis, Eleonora Tavazzi, et al.
Journal of the Neurological Sciences|March 25, 2018
Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI studyRobert Zivadinov, Niels Bergsland, Jesper Hagemeier, et al.
Journal of Biomedical Semantics|August 29, 2024
An extensible and unifying approach to retrospective clinical data modeling: the BrainTeaser OntologyGuglielmo Faggioli, Laura Menotti, Stefano Marchesin, et al.
Journal of Neurology|January 10, 2026
Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatmentsGiacomo Greco, Giovanni Della Porta, Francesco Masi, et al.
Journal of Neurology|August 21, 2025
Paramagnetic rim lesions are associated with choroid plexus inflammation and expansion over 5 years in people with multiple sclerosisJack A Reeves, Ashley Tranquille, Alexander Bartnik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 31, 2026
The supporting role of Visual Evoked Potentials for the diagnosis of Optic Neuritis within the 2022 ICON criteriaGiacomo Greco, Eleonora Rigoni, Francesco Masi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Immunomodulatory therapies delay disease progression in multiple sclerosisRoberto Bergamaschi, Silvana Quaglini, Eleonora Tavazzi, et al.
Nutrients|February 13, 2025
Dietary Inflammatory Score (DIS)'s and Lifestyle Inflammatory Score (LIS)'s Impact on Multiple Sclerosis SeverityMonica Guglielmetti, Cinzia Ferraris, Lenycia de Cassya Lopes Neri, et al.
Pageof 9